# A Randomized Controlled Trial on the Efficacy and Safety of Butylphthalide in Reducing Myocardial Infarction Size and Improving Outcomes in STEMI Patients After Primary PCI

> **NCT06704685** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Xiangya Hospital of Central South University** · enrollment: 40 (estimated)

## Conditions studied

- ST-segment Elevation Myocardial Infarction (STEMI)

## Interventions

- **DRUG:** Butylphthalide
- **DRUG:** Butylphthalide placebo

## Key facts

- **NCT ID:** NCT06704685
- **Lead sponsor:** Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2025-10-01
- **Final completion:** 2025-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-11-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06704685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06704685, "A Randomized Controlled Trial on the Efficacy and Safety of Butylphthalide in Reducing Myocardial Infarction Size and Improving Outcomes in STEMI Patients After Primary PCI". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06704685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*